Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
events
2
×
ajay royan
artificial intelligence
benevolentai
bio
biotech
computational neuroscience
cybernetics
disrupt
disrupt london
disrupt london 2016
dr. jackie hunter
emerging technologies
formal sciences
frederic moll
health
johnson & johnson
medical research
open problems
startups
tc
techcrunch disrupt sf 2019
technology in society
What
ceo
2
×
ajay
amyotrophic
arm
artificial
auris
benevolentbio
benevolentbio’s
better
billion
biomedical
bucket
challenge
come
company
confronting
consciousness
discover
disease
disrupt
drug
effectively
entrepreneurs
exists
firm
frederic
hansen
household
hunter
ice
include
intelligence
intuitive
inventors
investor
j
jackie
lateral
lead
manufacturer
Language
Current search:
events
×
ceo
×
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com
7 years ago
BenevolentBio’s artificial intelligence could discover a better treatment for ALS
